Enteris expands manufacturing, launches CDMO business unit

By The Science Advisory Board staff writers

May 3, 2021 -- Enteris BioPharma has expanded its Boonton, NJ, manufacturing facility and launched a contract development and manufacturing organization (CDMO) business unit.

The two actions will help the firm further develop and manufacture solid oral doses for biopharmaceutics classification system (BCS) III and IV compounds, it said.

The expanded facility is 32,000 sq ft, of which 6,000 sq ft is cleanroom space and 2,500 is for containment and processing of high-potency active pharmaceutical ingredients (APIs).


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.